Molecular prognostic indicators for breast cancer
Guerra, E.; Alberti, S.
Tumori 87(6): S23-S25
2001
ISSN/ISBN: 0300-8916 PMID: 11989614 Document Number: 531466
Document emailed within 1 workday
Related Documents
Thorpe, S.M.; Rose, C.; Rasmussen, B.B.; King, W.J.; DeSombre, E.R.; Blough, R.M.; Mouridsen, H.T.; Rossing, N.; Andersen, K.W. 1986: Steroid hormone receptors as prognostic indicators in primary breast cancer Breast Cancer Research and Treatment 7 Suppl: S91-S97Stepanova, E.V.; Zagrekova, E.I.; Ermilova, V.D.; Turbin, A.D.; Petrovichev, N.N.; Vysotskaia, I.V.; Dbar, Z.N.; Pashchenko, N.V.; Baryshnikov, A.I.; Lichinitser, M.R. 2003: Molecular-biological markers as prognostic factors in breast cancer of I-IIA stage Arkhiv Patologii 65(3): 14-18
Ogawa, Y.; Chung, Y.S.; Nakata, B.; Takatsuka, S.; Maeda, K.; Sawada, T.; Kato, Y.; Yoshikawa, K.; Sowa, M. 1995: Clinical significance of argyrophilic nucleolar organizer regions (AgNOR) and microvessel quantitation by staining for factor VIII-related antigen as prognostic indicators in stage i breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 22(Suppl 1): 66-70
Timovska, Y.O.; Pivnyuk, V.M.; Oliynichenko, G.P.; Anikushko, M.F.; Zachartseva, L.M.; Chekhun, V.F. 2009: Relation between pathomorphological response in tumors after neoadjuvant chemotherapy and clinico-morphological and molecular prognostic factors in patients with breast cancer Experimental Oncology 31(4): 231-236
Rudan, I.; Skorić, T.; Rudan, N. 1994: Breast cancer prognosis. II. Prognostic factors in patients with node-positive (N1-3) breast cancer Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 48(4-5): 165-170
Rudan, I.; Skorić, T.; Rudan, N. 1994: Breast cancer prognosis. I. Prognostic factors in patients with node-negative (N0) breast cancer Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 48(4-5): 159-163
Tominaga, T.; Abe, O.; Izuo, M.; Isono, K.; Enomoto, K.; Nishi, M.; Fukami, A.; Muto, T.; Morioka, Y.; Watanabe, H. 1993: Correlations between estrogen receptor and prognostic factors of patients with breast cancer. the Kanto Cooperative Study Group of Adjuvant Chemoendocrine Therapy for Breast Cancer, Japan Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(14): 2171-2176
Page, D.L.; Dupont, W.D. 1992: Benign breast disease: indicators of increased breast cancer risk Cancer Detection and Prevention 16(2): 93-97
Penault-Llorca, F.; Jacquemier, J.; Le Doussal, V.; Voigt, J.J. 1999: Quality challenge for immunohistochemistry: example of the ERBB-2 status in breast cancer. Group for Evaluation of Prognostic Factors in Immunohistochemistry in Breast Cancer (GEFPICS) Annales de Pathologie 19(4): 280-282
Feng, Y.-M.; Li, X.-Q.; Sun, B.-C.; Gao, X.-C.; Gu, L.; Niu, Y.; Hao, X.-S. 2006: Prognostic molecular classification of breast cancers based on gene expression profiling Zhonghua Zhong Liu Za Zhi 28(12): 900-906
Dimonte, M.; Leo, G.; Marsigliante, S.; Manca, C. 1999: The prognostic significance of 99mTc-MDP breast scintigraphy. a comparison with histological and molecular parameters La Radiologia Medica 98(5): 352-355
Hoon, D.S.; Bernet, L.; Cano, R.; Viale, G. 2014: Molecular analysis of sentinel lymph nodes and search for molecular signatures of the metastatic potential of breast cancer Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 58(2): 180-192
Demir, H.; Turna, H.; Can, G.; Ilvan, S. 2010: Clinicopathologic and prognostic evaluation of invasive breast carcinoma molecular subtypes and GATA3 expression Journal of BUON: Official Journal of the Balkan Union of Oncology 15(4): 774-782
Likaki-Karatza, E.; Ravazoula, P.; Androutsopoulos, G.; Michail, G.; Batistatou, A.; Tzorakoleftherakis, E.; Kalofonos, H.; Kourounis, G. 2006: Correlation of mammographic appearance and molecular prognostic factors in high-grade breast carcinomas European Journal of Gynaecological Oncology 27(1): 39-41
Scudla, V.; Wiedermann, B.; Wiedermann, D.; Indrák, K. 1984: Significance of prognostic indicators in multiple myeloma. I. Clinical, biochemical and radiographic indicators Vnitrni Lekarstvi 30(12): 1145-1155
1990: Prognostic importance of occult axillary lymph node micrometastases from breast cancers. International (Ludwig) Breast Cancer Study Group Lancet 335(8705): 1565-1568
Galosi, A.B.; Montironi, R.; Mazzuchelli, R.; Muzzonigro, G. 2007: Clinical pathology of prostate cancer: focus on diagnosis, predictive and prognostic factors and quality indicators Archivio Italiano di Urologia Andrologia: Organo Ufficiale di Societa Italiana di Ecografia Urologica e Nefrologica 79(1): 45-51
Krzemień, S.; Hołowiecki, J.; Jagoda, K.; Hołowiecka, B. 1990: Prognostic usefulness of certain defined indicators for achieving complete remission and survival of ANLL in adults: proposal of a prognostic scale Polski Tygodnik Lekarski 45(51-52): 1032-1036
Bucci, B.; Carico, E.; Rinaldi, A.; Froio, F.; Puce, Y.M.; D'Agnano, I.; Vecchione, A.; Brunetti, E. 2001: Biological indicators of aggressiveness in T1 ductal invasive breast cancer Anticancer Research 21(4b): 2949-2955
Tomasino, R.M.; Russo, A.; Bazan, V.; Morello, V.; Tralongo, V.; Nagar, C.; Salvato, M.; Taormina, P.; Marrazzo, A.; Nuara, R. 1993: Evaluation of integrated morpho-biological indicators in breast cancer In Vivo 7(6b): 601-605